The Blood XMRV Scientific Research Working Group was formed to design and carry out a study to determine whether xenotropic murine leukemia virus-related virus (XMRV) posed a threat to blood safety. Phase III results were published on Sept. 22, 2011 in Science. In an upcoming webinar study leaders Graham Simmons and Mike Busch will present their findings and discuss their consequences for blood safety and the understanding of this agent’s role in chronic fatigue syndrome (CFS).
Please register to attend the webinar on 14 October 2011 at 4:00 PM EDT.
Update: Materials from the webinar, including the slides, a video of the presentation, and answers to 10 common criticisms of the study have been posted at Research1st.